nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—ACHE—Irinotecan—hematologic cancer	0.063	0.107	CbGbCtD
Rivastigmine—BCHE—Triamcinolone—hematologic cancer	0.0501	0.085	CbGbCtD
Rivastigmine—BCHE—Irinotecan—hematologic cancer	0.038	0.0644	CbGbCtD
Rivastigmine—BCHE—Cisplatin—hematologic cancer	0.0309	0.0525	CbGbCtD
Rivastigmine—CYP2D6—Lomustine—hematologic cancer	0.0301	0.051	CbGbCtD
Rivastigmine—CYP2D6—Idarubicin—hematologic cancer	0.0268	0.0455	CbGbCtD
Rivastigmine—CYP2D6—Hydroxyurea—hematologic cancer	0.0228	0.0387	CbGbCtD
Rivastigmine—CYP3A4—Bexarotene—hematologic cancer	0.0206	0.0349	CbGbCtD
Rivastigmine—CYP2D6—Bortezomib—hematologic cancer	0.0198	0.0336	CbGbCtD
Rivastigmine—CYP3A4—Lomustine—hematologic cancer	0.0191	0.0325	CbGbCtD
Rivastigmine—CYP3A4—Busulfan—hematologic cancer	0.0191	0.0325	CbGbCtD
Rivastigmine—CYP3A4—Thiotepa—hematologic cancer	0.017	0.0289	CbGbCtD
Rivastigmine—CYP2D6—Imatinib—hematologic cancer	0.0145	0.0247	CbGbCtD
Rivastigmine—CYP3A4—Methoxsalen—hematologic cancer	0.0133	0.0225	CbGbCtD
Rivastigmine—CYP2D6—Nilotinib—hematologic cancer	0.0132	0.0224	CbGbCtD
Rivastigmine—CYP2D6—Vinorelbine—hematologic cancer	0.0131	0.0222	CbGbCtD
Rivastigmine—CYP3A4—Bortezomib—hematologic cancer	0.0126	0.0214	CbGbCtD
Rivastigmine—CYP3A4—Daunorubicin—hematologic cancer	0.0121	0.0205	CbGbCtD
Rivastigmine—CYP3A4—Cytarabine—hematologic cancer	0.0106	0.0181	CbGbCtD
Rivastigmine—CYP3A4—Teniposide—hematologic cancer	0.0105	0.0178	CbGbCtD
Rivastigmine—CYP3A4—Ifosfamide—hematologic cancer	0.00967	0.0164	CbGbCtD
Rivastigmine—CYP3A4—Imatinib—hematologic cancer	0.00924	0.0157	CbGbCtD
Rivastigmine—CYP3A4—Ruxolitinib—hematologic cancer	0.0087	0.0148	CbGbCtD
Rivastigmine—CYP3A4—Nilotinib—hematologic cancer	0.0084	0.0142	CbGbCtD
Rivastigmine—CYP3A4—Vinorelbine—hematologic cancer	0.00833	0.0141	CbGbCtD
Rivastigmine—CYP2D6—Vinblastine—hematologic cancer	0.00807	0.0137	CbGbCtD
Rivastigmine—CYP3A4—Triamcinolone—hematologic cancer	0.00762	0.0129	CbGbCtD
Rivastigmine—CYP3A4—Dasatinib—hematologic cancer	0.00742	0.0126	CbGbCtD
Rivastigmine—CYP3A4—Mitoxantrone—hematologic cancer	0.00733	0.0124	CbGbCtD
Rivastigmine—CYP3A4—Betamethasone—hematologic cancer	0.00653	0.0111	CbGbCtD
Rivastigmine—CYP3A4—Prednisolone—hematologic cancer	0.00645	0.0109	CbGbCtD
Rivastigmine—CYP3A4—Prednisone—hematologic cancer	0.00609	0.0103	CbGbCtD
Rivastigmine—CYP2D6—Dexamethasone—hematologic cancer	0.00598	0.0101	CbGbCtD
Rivastigmine—CYP3A4—Irinotecan—hematologic cancer	0.00577	0.00979	CbGbCtD
Rivastigmine—CYP3A4—Vinblastine—hematologic cancer	0.00513	0.00871	CbGbCtD
Rivastigmine—CYP3A4—Vincristine—hematologic cancer	0.00504	0.00856	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—hematologic cancer	0.00496	0.00841	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—hematologic cancer	0.00462	0.00784	CbGbCtD
Rivastigmine—CYP3A4—Dexamethasone—hematologic cancer	0.0038	0.00645	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—hematologic cancer	0.00315	0.00535	CbGbCtD
Rivastigmine—BCHE—Metabolism of proteins—CALR—hematologic cancer	3.16e-05	0.000625	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	3.14e-05	0.000623	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.13e-05	0.00062	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMMR—hematologic cancer	3.12e-05	0.000618	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—IDH2—hematologic cancer	3.12e-05	0.000618	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	3.1e-05	0.000614	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	3.05e-05	0.000604	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MDM2—hematologic cancer	3.04e-05	0.000603	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—FHL2—hematologic cancer	3e-05	0.000593	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.96e-05	0.000586	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.94e-05	0.000583	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AGRN—hematologic cancer	2.94e-05	0.000582	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ARNTL—hematologic cancer	2.94e-05	0.000581	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.88e-05	0.00057	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.87e-05	0.000569	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ACP5—hematologic cancer	2.86e-05	0.000565	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CA9—hematologic cancer	2.86e-05	0.000565	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	2.83e-05	0.00056	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NCOR2—hematologic cancer	2.82e-05	0.000558	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMMR—hematologic cancer	2.79e-05	0.000551	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—IDH2—hematologic cancer	2.79e-05	0.000551	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—MDM2—hematologic cancer	2.72e-05	0.000538	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—IDH1—hematologic cancer	2.68e-05	0.000531	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.68e-05	0.000531	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.66e-05	0.000527	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TXN—hematologic cancer	2.65e-05	0.000526	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCC3—hematologic cancer	2.65e-05	0.000526	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTO1—hematologic cancer	2.65e-05	0.000526	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.63e-05	0.00052	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—FTCD—hematologic cancer	2.62e-05	0.000519	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GMPS—hematologic cancer	2.62e-05	0.000519	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PHYH—hematologic cancer	2.62e-05	0.000519	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ARNTL—hematologic cancer	2.62e-05	0.000518	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SPHK1—hematologic cancer	2.6e-05	0.000514	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CA9—hematologic cancer	2.55e-05	0.000504	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ACP5—hematologic cancer	2.55e-05	0.000504	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOR2—hematologic cancer	2.51e-05	0.000498	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—UGT1A1—hematologic cancer	2.5e-05	0.000494	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.45e-05	0.000484	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CRABP1—hematologic cancer	2.43e-05	0.000481	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC22A1—hematologic cancer	2.43e-05	0.000481	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.4e-05	0.000475	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—IDH1—hematologic cancer	2.4e-05	0.000474	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TXN—hematologic cancer	2.37e-05	0.000469	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCC3—hematologic cancer	2.37e-05	0.000469	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTO1—hematologic cancer	2.37e-05	0.000469	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALOX5—hematologic cancer	2.37e-05	0.000468	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.37e-05	0.000468	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SPHK1—hematologic cancer	2.32e-05	0.000459	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NUP98—hematologic cancer	2.29e-05	0.000454	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.24e-05	0.000443	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—UGT1A1—hematologic cancer	2.23e-05	0.000441	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ADCY7—hematologic cancer	2.22e-05	0.00044	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NCOA3—hematologic cancer	2.22e-05	0.00044	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NUP214—hematologic cancer	2.21e-05	0.000437	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.21e-05	0.000437	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.19e-05	0.000433	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.18e-05	0.000432	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CRABP1—hematologic cancer	2.17e-05	0.000429	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC22A1—hematologic cancer	2.17e-05	0.000429	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTR—hematologic cancer	2.16e-05	0.000428	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCG2—hematologic cancer	2.16e-05	0.000428	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ENO2—hematologic cancer	2.12e-05	0.00042	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALOX5—hematologic cancer	2.11e-05	0.000418	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—DCK—hematologic cancer	2.1e-05	0.000415	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ASNS—hematologic cancer	2.1e-05	0.000415	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.1e-05	0.000415	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTT1—hematologic cancer	2.06e-05	0.000407	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.06e-05	0.000407	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NUP98—hematologic cancer	2.04e-05	0.000405	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.03e-05	0.000401	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.03e-05	0.000401	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SDC1—hematologic cancer	2.01e-05	0.000398	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2e-05	0.000395	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HDC—hematologic cancer	1.99e-05	0.000393	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ADCY7—hematologic cancer	1.98e-05	0.000393	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOA3—hematologic cancer	1.98e-05	0.000393	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NUP214—hematologic cancer	1.97e-05	0.00039	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.95e-05	0.000386	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.95e-05	0.000385	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTR—hematologic cancer	1.93e-05	0.000382	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCG2—hematologic cancer	1.93e-05	0.000382	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.92e-05	0.00038	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.9e-05	0.000376	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ENO2—hematologic cancer	1.89e-05	0.000375	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTT1—hematologic cancer	1.84e-05	0.000364	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CDA—hematologic cancer	1.82e-05	0.00036	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.81e-05	0.000359	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.81e-05	0.000358	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SDC1—hematologic cancer	1.79e-05	0.000355	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CCL2—hematologic cancer	1.76e-05	0.000348	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PC—hematologic cancer	1.75e-05	0.000346	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.71e-05	0.000339	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.71e-05	0.000339	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.71e-05	0.000339	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.71e-05	0.000339	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NQO1—hematologic cancer	1.71e-05	0.000339	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CD44—hematologic cancer	1.71e-05	0.000339	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.69e-05	0.000335	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.69e-05	0.000334	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GBA—hematologic cancer	1.69e-05	0.000334	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.68e-05	0.000332	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—HRAS—hematologic cancer	1.67e-05	0.000331	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.62e-05	0.00032	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYCS—hematologic cancer	1.62e-05	0.00032	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HSP90AA1—hematologic cancer	1.61e-05	0.000318	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CCL2—hematologic cancer	1.57e-05	0.000311	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.57e-05	0.00031	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.55e-05	0.000306	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NQO1—hematologic cancer	1.53e-05	0.000302	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CD44—hematologic cancer	1.53e-05	0.000302	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.49e-05	0.000296	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—HRAS—hematologic cancer	1.49e-05	0.000295	CbGpPWpGaD
Rivastigmine—Ill-defined disorder—Methotrexate—hematologic cancer	1.48e-05	4.1e-05	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—hematologic cancer	1.47e-05	4.1e-05	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—hematologic cancer	1.47e-05	4.08e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Betamethasone—hematologic cancer	1.47e-05	4.08e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Dexamethasone—hematologic cancer	1.47e-05	4.08e-05	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—hematologic cancer	1.47e-05	4.08e-05	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—hematologic cancer	1.47e-05	4.08e-05	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—hematologic cancer	1.47e-05	4.07e-05	CcSEcCtD
Rivastigmine—Tension—Epirubicin—hematologic cancer	1.46e-05	4.06e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.46e-05	4.05e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.46e-05	4.05e-05	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—hematologic cancer	1.46e-05	4.05e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Triamcinolone—hematologic cancer	1.45e-05	4.02e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.45e-05	0.000287	CbGpPWpGaD
Rivastigmine—Nervousness—Epirubicin—hematologic cancer	1.45e-05	4.01e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CYCS—hematologic cancer	1.44e-05	0.000286	CbGpPWpGaD
Rivastigmine—Back pain—Epirubicin—hematologic cancer	1.44e-05	4e-05	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—hematologic cancer	1.43e-05	3.99e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—HSP90AA1—hematologic cancer	1.43e-05	0.000284	CbGpPWpGaD
Rivastigmine—Malaise—Methotrexate—hematologic cancer	1.43e-05	3.98e-05	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—hematologic cancer	1.43e-05	3.98e-05	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—hematologic cancer	1.43e-05	3.97e-05	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—hematologic cancer	1.43e-05	3.97e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTP1—hematologic cancer	1.43e-05	0.000282	CbGpPWpGaD
Rivastigmine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.43e-05	3.96e-05	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—hematologic cancer	1.42e-05	3.94e-05	CcSEcCtD
Rivastigmine—Urticaria—Dexamethasone—hematologic cancer	1.42e-05	3.93e-05	CcSEcCtD
Rivastigmine—Urticaria—Betamethasone—hematologic cancer	1.42e-05	3.93e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.41e-05	3.93e-05	CcSEcCtD
Rivastigmine—Dizziness—Prednisolone—hematologic cancer	1.41e-05	3.92e-05	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—hematologic cancer	1.41e-05	3.92e-05	CcSEcCtD
Rivastigmine—Asthenia—Triamcinolone—hematologic cancer	1.41e-05	3.92e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Betamethasone—hematologic cancer	1.41e-05	3.91e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Dexamethasone—hematologic cancer	1.41e-05	3.91e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Dexamethasone—hematologic cancer	1.41e-05	3.91e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Betamethasone—hematologic cancer	1.41e-05	3.91e-05	CcSEcCtD
Rivastigmine—Nausea—Cisplatin—hematologic cancer	1.4e-05	3.9e-05	CcSEcCtD
Rivastigmine—Insomnia—Prednisone—hematologic cancer	1.4e-05	3.9e-05	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—hematologic cancer	1.4e-05	3.89e-05	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—hematologic cancer	1.4e-05	3.88e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisone—hematologic cancer	1.39e-05	3.87e-05	CcSEcCtD
Rivastigmine—Pruritus—Triamcinolone—hematologic cancer	1.39e-05	3.86e-05	CcSEcCtD
Rivastigmine—Cough—Methotrexate—hematologic cancer	1.39e-05	3.85e-05	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—hematologic cancer	1.39e-05	3.85e-05	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—hematologic cancer	1.38e-05	3.83e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.38e-05	0.000273	CbGpPWpGaD
Rivastigmine—Convulsion—Methotrexate—hematologic cancer	1.38e-05	3.83e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.38e-05	0.000273	CbGpPWpGaD
Rivastigmine—Vomiting—Etoposide—hematologic cancer	1.38e-05	3.83e-05	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—hematologic cancer	1.38e-05	3.82e-05	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—hematologic cancer	1.38e-05	3.82e-05	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—hematologic cancer	1.38e-05	3.82e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.37e-05	0.000271	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.37e-05	0.000271	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—DCK—hematologic cancer	1.37e-05	0.000271	CbGpPWpGaD
Rivastigmine—Agitation—Epirubicin—hematologic cancer	1.37e-05	3.8e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Prednisone—hematologic cancer	1.37e-05	3.8e-05	CcSEcCtD
Rivastigmine—Rash—Etoposide—hematologic cancer	1.37e-05	3.79e-05	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—hematologic cancer	1.36e-05	3.79e-05	CcSEcCtD
Rivastigmine—Headache—Etoposide—hematologic cancer	1.36e-05	3.77e-05	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—hematologic cancer	1.36e-05	3.77e-05	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—hematologic cancer	1.35e-05	3.76e-05	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—hematologic cancer	1.35e-05	3.76e-05	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—hematologic cancer	1.35e-05	3.76e-05	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—hematologic cancer	1.35e-05	3.75e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.35e-05	0.000267	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCB1—hematologic cancer	1.35e-05	0.000267	CbGpPWpGaD
Rivastigmine—Decreased appetite—Prednisone—hematologic cancer	1.35e-05	3.75e-05	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—hematologic cancer	1.35e-05	3.74e-05	CcSEcCtD
Rivastigmine—Rash—Prednisolone—hematologic cancer	1.35e-05	3.74e-05	CcSEcCtD
Rivastigmine—Dermatitis—Prednisolone—hematologic cancer	1.35e-05	3.74e-05	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.34e-05	3.73e-05	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—hematologic cancer	1.34e-05	3.73e-05	CcSEcCtD
Rivastigmine—Fatigue—Prednisone—hematologic cancer	1.34e-05	3.72e-05	CcSEcCtD
Rivastigmine—Headache—Prednisolone—hematologic cancer	1.34e-05	3.72e-05	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—hematologic cancer	1.34e-05	3.71e-05	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—hematologic cancer	1.34e-05	3.71e-05	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—hematologic cancer	1.34e-05	3.71e-05	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—hematologic cancer	1.33e-05	3.71e-05	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—hematologic cancer	1.33e-05	3.7e-05	CcSEcCtD
Rivastigmine—Constipation—Prednisone—hematologic cancer	1.33e-05	3.69e-05	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—hematologic cancer	1.32e-05	3.68e-05	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—hematologic cancer	1.31e-05	3.65e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTM1—hematologic cancer	1.31e-05	0.00026	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NCOR1—hematologic cancer	1.31e-05	0.00026	CbGpPWpGaD
Rivastigmine—Confusional state—Methotrexate—hematologic cancer	1.31e-05	3.63e-05	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—hematologic cancer	1.31e-05	3.63e-05	CcSEcCtD
Rivastigmine—Dizziness—Triamcinolone—hematologic cancer	1.3e-05	3.61e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—HDC—hematologic cancer	1.3e-05	0.000257	CbGpPWpGaD
Rivastigmine—Cough—Epirubicin—hematologic cancer	1.3e-05	3.61e-05	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—hematologic cancer	1.3e-05	3.6e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.29e-05	0.000256	CbGpPWpGaD
Rivastigmine—Convulsion—Epirubicin—hematologic cancer	1.29e-05	3.58e-05	CcSEcCtD
Rivastigmine—Infection—Methotrexate—hematologic cancer	1.29e-05	3.58e-05	CcSEcCtD
Rivastigmine—Nausea—Etoposide—hematologic cancer	1.29e-05	3.57e-05	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—hematologic cancer	1.28e-05	3.57e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.28e-05	0.000254	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.28e-05	0.000254	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Prednisone—hematologic cancer	1.28e-05	3.55e-05	CcSEcCtD
Rivastigmine—Asthenia—Dexamethasone—hematologic cancer	1.28e-05	3.55e-05	CcSEcCtD
Rivastigmine—Asthenia—Betamethasone—hematologic cancer	1.28e-05	3.55e-05	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.28e-05	3.55e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—GSTP1—hematologic cancer	1.27e-05	0.000252	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Methotrexate—hematologic cancer	1.27e-05	3.53e-05	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—hematologic cancer	1.27e-05	3.53e-05	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—hematologic cancer	1.27e-05	3.53e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Prednisone—hematologic cancer	1.27e-05	3.53e-05	CcSEcCtD
Rivastigmine—Nausea—Prednisolone—hematologic cancer	1.27e-05	3.52e-05	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—hematologic cancer	1.27e-05	3.52e-05	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—hematologic cancer	1.27e-05	3.52e-05	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—hematologic cancer	1.27e-05	3.52e-05	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—hematologic cancer	1.27e-05	3.51e-05	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—hematologic cancer	1.26e-05	3.51e-05	CcSEcCtD
Rivastigmine—Pruritus—Dexamethasone—hematologic cancer	1.26e-05	3.5e-05	CcSEcCtD
Rivastigmine—Pruritus—Betamethasone—hematologic cancer	1.26e-05	3.5e-05	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—hematologic cancer	1.26e-05	3.5e-05	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.26e-05	3.49e-05	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—hematologic cancer	1.25e-05	3.48e-05	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—hematologic cancer	1.25e-05	3.48e-05	CcSEcCtD
Rivastigmine—Vomiting—Triamcinolone—hematologic cancer	1.25e-05	3.47e-05	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—hematologic cancer	1.24e-05	3.45e-05	CcSEcCtD
Rivastigmine—Rash—Triamcinolone—hematologic cancer	1.24e-05	3.44e-05	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—hematologic cancer	1.24e-05	3.44e-05	CcSEcCtD
Rivastigmine—Dermatitis—Triamcinolone—hematologic cancer	1.24e-05	3.44e-05	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—hematologic cancer	1.24e-05	3.44e-05	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—hematologic cancer	1.24e-05	3.44e-05	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—hematologic cancer	1.23e-05	3.43e-05	CcSEcCtD
Rivastigmine—Urticaria—Prednisone—hematologic cancer	1.23e-05	3.43e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.23e-05	0.000244	CbGpPWpGaD
Rivastigmine—Headache—Triamcinolone—hematologic cancer	1.23e-05	3.42e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Prednisone—hematologic cancer	1.23e-05	3.41e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Prednisone—hematologic cancer	1.23e-05	3.41e-05	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—hematologic cancer	1.22e-05	3.4e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Betamethasone—hematologic cancer	1.22e-05	3.39e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Dexamethasone—hematologic cancer	1.22e-05	3.39e-05	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—hematologic cancer	1.22e-05	3.38e-05	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—hematologic cancer	1.21e-05	3.37e-05	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—hematologic cancer	1.21e-05	3.37e-05	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—hematologic cancer	1.21e-05	3.36e-05	CcSEcCtD
Rivastigmine—Infection—Epirubicin—hematologic cancer	1.21e-05	3.35e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ABCB1—hematologic cancer	1.2e-05	0.000239	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.2e-05	0.000238	CbGpPWpGaD
Rivastigmine—Cough—Doxorubicin—hematologic cancer	1.2e-05	3.34e-05	CcSEcCtD
Rivastigmine—Shock—Epirubicin—hematologic cancer	1.19e-05	3.32e-05	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—hematologic cancer	1.19e-05	3.31e-05	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—hematologic cancer	1.19e-05	3.31e-05	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—hematologic cancer	1.19e-05	3.3e-05	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—hematologic cancer	1.19e-05	3.3e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—CDA—hematologic cancer	1.19e-05	0.000235	CbGpPWpGaD
Rivastigmine—Tachycardia—Epirubicin—hematologic cancer	1.19e-05	3.29e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.18e-05	3.28e-05	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—hematologic cancer	1.18e-05	3.28e-05	CcSEcCtD
Rivastigmine—Dizziness—Dexamethasone—hematologic cancer	1.18e-05	3.27e-05	CcSEcCtD
Rivastigmine—Dizziness—Betamethasone—hematologic cancer	1.18e-05	3.27e-05	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—hematologic cancer	1.17e-05	3.26e-05	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—hematologic cancer	1.17e-05	3.26e-05	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—hematologic cancer	1.17e-05	3.26e-05	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—hematologic cancer	1.17e-05	3.26e-05	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—hematologic cancer	1.17e-05	3.26e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—CA9—hematologic cancer	1.17e-05	0.000232	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.17e-05	0.000232	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—hematologic cancer	1.17e-05	0.000232	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOR1—hematologic cancer	1.17e-05	0.000232	CbGpPWpGaD
Rivastigmine—Anxiety—Doxorubicin—hematologic cancer	1.17e-05	3.24e-05	CcSEcCtD
Rivastigmine—Nausea—Triamcinolone—hematologic cancer	1.17e-05	3.24e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—hematologic cancer	1.17e-05	3.24e-05	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.16e-05	3.23e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—MTHFR—hematologic cancer	1.16e-05	0.000229	CbGpPWpGaD
Rivastigmine—Discomfort—Doxorubicin—hematologic cancer	1.16e-05	3.22e-05	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—hematologic cancer	1.16e-05	3.21e-05	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—hematologic cancer	1.16e-05	3.21e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.16e-05	0.000229	CbGpPWpGaD
Rivastigmine—Somnolence—Methotrexate—hematologic cancer	1.15e-05	3.2e-05	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—hematologic cancer	1.15e-05	3.18e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisone—hematologic cancer	1.14e-05	3.18e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—PC—hematologic cancer	1.14e-05	0.000226	CbGpPWpGaD
Rivastigmine—Dyspepsia—Methotrexate—hematologic cancer	1.14e-05	3.17e-05	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—hematologic cancer	1.13e-05	3.15e-05	CcSEcCtD
Rivastigmine—Vomiting—Betamethasone—hematologic cancer	1.13e-05	3.15e-05	CcSEcCtD
Rivastigmine—Vomiting—Dexamethasone—hematologic cancer	1.13e-05	3.15e-05	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—hematologic cancer	1.13e-05	3.15e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—hematologic cancer	1.13e-05	3.13e-05	CcSEcCtD
Rivastigmine—Rash—Dexamethasone—hematologic cancer	1.12e-05	3.12e-05	CcSEcCtD
Rivastigmine—Rash—Betamethasone—hematologic cancer	1.12e-05	3.12e-05	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—hematologic cancer	1.12e-05	3.12e-05	CcSEcCtD
Rivastigmine—Dermatitis—Dexamethasone—hematologic cancer	1.12e-05	3.12e-05	CcSEcCtD
Rivastigmine—Dermatitis—Betamethasone—hematologic cancer	1.12e-05	3.12e-05	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.12e-05	3.11e-05	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—hematologic cancer	1.12e-05	3.11e-05	CcSEcCtD
Rivastigmine—Headache—Dexamethasone—hematologic cancer	1.12e-05	3.1e-05	CcSEcCtD
Rivastigmine—Headache—Betamethasone—hematologic cancer	1.12e-05	3.1e-05	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—hematologic cancer	1.12e-05	3.1e-05	CcSEcCtD
Rivastigmine—Asthenia—Prednisone—hematologic cancer	1.11e-05	3.09e-05	CcSEcCtD
Rivastigmine—Pain—Methotrexate—hematologic cancer	1.11e-05	3.08e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.11e-05	3.07e-05	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—hematologic cancer	1.11e-05	3.07e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.1e-05	0.000219	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GBA—hematologic cancer	1.1e-05	0.000219	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Doxorubicin—hematologic cancer	1.1e-05	3.06e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.1e-05	0.000218	CbGpPWpGaD
Rivastigmine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.1e-05	3.06e-05	CcSEcCtD
Rivastigmine—Pruritus—Prednisone—hematologic cancer	1.1e-05	3.05e-05	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—hematologic cancer	1.1e-05	3.05e-05	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—hematologic cancer	1.1e-05	3.05e-05	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—hematologic cancer	1.09e-05	3.03e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—hematologic cancer	1.09e-05	3.03e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.09e-05	0.000216	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.09e-05	0.000216	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TXN—hematologic cancer	1.09e-05	0.000216	CbGpPWpGaD
Rivastigmine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.09e-05	3.02e-05	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—hematologic cancer	1.08e-05	3.01e-05	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—hematologic cancer	1.08e-05	3e-05	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—hematologic cancer	1.07e-05	2.97e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—hematologic cancer	1.07e-05	2.97e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—hematologic cancer	1.07e-05	2.97e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.07e-05	0.000211	CbGpPWpGaD
Rivastigmine—Diarrhoea—Prednisone—hematologic cancer	1.06e-05	2.95e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.06e-05	2.95e-05	CcSEcCtD
Rivastigmine—Nausea—Dexamethasone—hematologic cancer	1.06e-05	2.94e-05	CcSEcCtD
Rivastigmine—Nausea—Betamethasone—hematologic cancer	1.06e-05	2.94e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—hematologic cancer	1.06e-05	2.93e-05	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—hematologic cancer	1.05e-05	2.92e-05	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.05e-05	2.91e-05	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—hematologic cancer	1.05e-05	2.91e-05	CcSEcCtD
Rivastigmine—Pain—Epirubicin—hematologic cancer	1.04e-05	2.88e-05	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—hematologic cancer	1.04e-05	2.88e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—MTHFR—hematologic cancer	1.03e-05	0.000205	CbGpPWpGaD
Rivastigmine—Urticaria—Methotrexate—hematologic cancer	1.03e-05	2.86e-05	CcSEcCtD
Rivastigmine—Dizziness—Prednisone—hematologic cancer	1.03e-05	2.85e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—hematologic cancer	1.03e-05	2.85e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—hematologic cancer	1.03e-05	2.85e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.02e-05	0.000203	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.02e-05	2.84e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Rivastigmine—Insomnia—Doxorubicin—hematologic cancer	1.02e-05	2.82e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—MTAP—hematologic cancer	1.01e-05	0.0002	CbGpPWpGaD
Rivastigmine—Paraesthesia—Doxorubicin—hematologic cancer	1.01e-05	2.8e-05	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—hematologic cancer	1e-05	2.78e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—hematologic cancer	1e-05	2.78e-05	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—hematologic cancer	9.99e-06	2.77e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	9.96e-06	0.000197	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CRABP1—hematologic cancer	9.96e-06	0.000197	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Epirubicin—hematologic cancer	9.93e-06	2.76e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—hematologic cancer	9.89e-06	2.75e-05	CcSEcCtD
Rivastigmine—Vomiting—Prednisone—hematologic cancer	9.87e-06	2.74e-05	CcSEcCtD
Rivastigmine—Rash—Prednisone—hematologic cancer	9.79e-06	2.72e-05	CcSEcCtD
Rivastigmine—Dermatitis—Prednisone—hematologic cancer	9.78e-06	2.72e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—hematologic cancer	9.77e-06	2.71e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—PIK3CG—hematologic cancer	9.74e-06	0.000193	CbGpPWpGaD
Rivastigmine—Headache—Prednisone—hematologic cancer	9.73e-06	2.7e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—ALOX5—hematologic cancer	9.71e-06	0.000192	CbGpPWpGaD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.7e-06	2.69e-05	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—hematologic cancer	9.69e-06	2.69e-05	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—hematologic cancer	9.65e-06	2.68e-05	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—hematologic cancer	9.61e-06	2.67e-05	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—hematologic cancer	9.61e-06	2.67e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—hematologic cancer	9.6e-06	2.67e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—hematologic cancer	9.6e-06	2.67e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—hematologic cancer	9.56e-06	2.66e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—NUP98—hematologic cancer	9.4e-06	0.000186	CbGpPWpGaD
Rivastigmine—Asthenia—Methotrexate—hematologic cancer	9.31e-06	2.59e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—hematologic cancer	9.26e-06	2.57e-05	CcSEcCtD
Rivastigmine—Nausea—Prednisone—hematologic cancer	9.22e-06	2.56e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.19e-06	2.55e-05	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—hematologic cancer	9.18e-06	2.55e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—ADCY7—hematologic cancer	9.12e-06	0.000181	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOA3—hematologic cancer	9.12e-06	0.000181	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.11e-06	0.00018	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NUP214—hematologic cancer	9.06e-06	0.000179	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CREBBP—hematologic cancer	9.03e-06	0.000179	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FHL2—hematologic cancer	9.01e-06	0.000178	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Epirubicin—hematologic cancer	8.95e-06	2.48e-05	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—hematologic cancer	8.93e-06	2.48e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—hematologic cancer	8.88e-06	2.47e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—hematologic cancer	8.88e-06	2.47e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—hematologic cancer	8.88e-06	2.47e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—ABCG2—hematologic cancer	8.88e-06	0.000176	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTR—hematologic cancer	8.88e-06	0.000176	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AGRN—hematologic cancer	8.83e-06	0.000175	CbGpPWpGaD
Rivastigmine—Asthenia—Epirubicin—hematologic cancer	8.71e-06	2.42e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—ENO2—hematologic cancer	8.7e-06	0.000172	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CG—hematologic cancer	8.69e-06	0.000172	CbGpPWpGaD
Rivastigmine—Pruritus—Epirubicin—hematologic cancer	8.59e-06	2.39e-05	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—hematologic cancer	8.58e-06	2.38e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—PIK3CD—hematologic cancer	8.56e-06	0.000169	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALB—hematologic cancer	8.45e-06	0.000167	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—hematologic cancer	8.44e-06	0.000167	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—IDH2—hematologic cancer	8.37e-06	0.000166	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMMR—hematologic cancer	8.37e-06	0.000166	CbGpPWpGaD
Rivastigmine—Diarrhoea—Epirubicin—hematologic cancer	8.31e-06	2.31e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—hematologic cancer	8.28e-06	2.3e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—SDC1—hematologic cancer	8.25e-06	0.000163	CbGpPWpGaD
Rivastigmine—Vomiting—Methotrexate—hematologic cancer	8.25e-06	2.29e-05	CcSEcCtD
Rivastigmine—Rash—Methotrexate—hematologic cancer	8.18e-06	2.27e-05	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—hematologic cancer	8.17e-06	2.27e-05	CcSEcCtD
Rivastigmine—Headache—Methotrexate—hematologic cancer	8.13e-06	2.26e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—PIK3R1—hematologic cancer	8.08e-06	0.00016	CbGpPWpGaD
Rivastigmine—Asthenia—Doxorubicin—hematologic cancer	8.06e-06	2.24e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CREBBP—hematologic cancer	8.05e-06	0.000159	CbGpPWpGaD
Rivastigmine—Dizziness—Epirubicin—hematologic cancer	8.03e-06	2.23e-05	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—hematologic cancer	7.95e-06	2.21e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.87e-06	0.000156	CbGpPWpGaD
Rivastigmine—Vomiting—Epirubicin—hematologic cancer	7.72e-06	2.14e-05	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—hematologic cancer	7.71e-06	2.14e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—hematologic cancer	7.69e-06	2.14e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—CA9—hematologic cancer	7.66e-06	0.000152	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACP5—hematologic cancer	7.66e-06	0.000152	CbGpPWpGaD
Rivastigmine—Rash—Epirubicin—hematologic cancer	7.66e-06	2.13e-05	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—hematologic cancer	7.65e-06	2.12e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—PIK3CD—hematologic cancer	7.64e-06	0.000151	CbGpPWpGaD
Rivastigmine—Headache—Epirubicin—hematologic cancer	7.61e-06	2.11e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.56e-06	0.00015	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALB—hematologic cancer	7.54e-06	0.000149	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CB—hematologic cancer	7.46e-06	0.000148	CbGpPWpGaD
Rivastigmine—Dizziness—Doxorubicin—hematologic cancer	7.43e-06	2.06e-05	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—hematologic cancer	7.21e-06	2e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—PIK3R1—hematologic cancer	7.21e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—IDH1—hematologic cancer	7.2e-06	0.000143	CbGpPWpGaD
Rivastigmine—Vomiting—Doxorubicin—hematologic cancer	7.14e-06	1.98e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—TXN—hematologic cancer	7.12e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.12e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.12e-06	0.000141	CbGpPWpGaD
Rivastigmine—Rash—Doxorubicin—hematologic cancer	7.08e-06	1.97e-05	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—hematologic cancer	7.08e-06	1.97e-05	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—hematologic cancer	7.04e-06	1.95e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—NQO1—hematologic cancer	7.02e-06	0.000139	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CD44—hematologic cancer	7.02e-06	0.000139	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.97e-06	0.000138	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.69e-06	0.000132	CbGpPWpGaD
Rivastigmine—Nausea—Doxorubicin—hematologic cancer	6.67e-06	1.85e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—PIK3CB—hematologic cancer	6.65e-06	0.000132	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYCS—hematologic cancer	6.64e-06	0.000131	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	6.6e-06	0.000131	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.51e-06	0.000129	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.51e-06	0.000129	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTEN—hematologic cancer	6.45e-06	0.000128	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.35e-06	0.000126	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—EP300—hematologic cancer	6.15e-06	0.000122	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NUP98—hematologic cancer	6.15e-06	0.000122	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.97e-06	0.000118	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.97e-06	0.000118	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.92e-06	0.000117	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.85e-06	0.000116	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.8e-06	0.000115	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTR—hematologic cancer	5.8e-06	0.000115	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTEN—hematologic cancer	5.75e-06	0.000114	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ENO2—hematologic cancer	5.69e-06	0.000113	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCB1—hematologic cancer	5.54e-06	0.00011	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.52e-06	0.000109	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—EP300—hematologic cancer	5.48e-06	0.000109	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SDC1—hematologic cancer	5.4e-06	0.000107	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—hematologic cancer	5.38e-06	0.000106	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOR1—hematologic cancer	5.38e-06	0.000106	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.75e-06	9.41e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CD44—hematologic cancer	4.59e-06	9.08e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.59e-06	9.08e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—hematologic cancer	4.55e-06	9e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYCS—hematologic cancer	4.34e-06	8.59e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.31e-06	8.54e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—hematologic cancer	4.06e-06	8.03e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.99e-06	7.9e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.83e-06	7.57e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—hematologic cancer	3.71e-06	7.35e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.7e-06	7.33e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.62e-06	7.17e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.52e-06	6.96e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.52e-06	6.96e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.51e-06	6.95e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALB—hematologic cancer	3.47e-06	6.86e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.31e-06	6.56e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—hematologic cancer	3.31e-06	6.56e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.11e-06	6.15e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.06e-06	6.06e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.64e-06	5.23e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.61e-06	5.17e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—EP300—hematologic cancer	2.52e-06	4.99e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.42e-06	4.79e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.3e-06	4.54e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALB—hematologic cancer	2.27e-06	4.49e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.17e-06	4.29e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2e-06	3.96e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.87e-06	3.69e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.73e-06	3.42e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—EP300—hematologic cancer	1.65e-06	3.26e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.52e-06	3.02e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.22e-06	2.41e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—hematologic cancer	9.96e-07	1.97e-05	CbGpPWpGaD
